1. Home
  2. ENTG vs PEN Comparison

ENTG vs PEN Comparison

Compare ENTG & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entegris Inc.

ENTG

Entegris Inc.

HOLD

Current Price

$89.12

Market Cap

13.1B

Sector

Industrials

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$299.66

Market Cap

10.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTG
PEN
Founded
1966
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1B
10.9B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
ENTG
PEN
Price
$89.12
$299.66
Analyst Decision
Buy
Strong Buy
Analyst Count
8
16
Target Price
$98.25
$307.19
AVG Volume (30 Days)
2.8M
479.9K
Earning Date
10-30-2025
11-05-2025
Dividend Yield
0.45%
N/A
EPS Growth
26.59
367.34
EPS
1.90
4.14
Revenue
$3,222,508,000.00
$1,333,798,000.00
Revenue This Year
$0.27
$16.77
Revenue Next Year
$6.22
$14.12
P/E Ratio
$46.93
$72.65
Revenue Growth
0.59
14.61
52 Week Low
$60.75
$221.26
52 Week High
$112.36
$310.00

Technical Indicators

Market Signals
Indicator
ENTG
PEN
Relative Strength Index (RSI) 61.29 67.77
Support Level $72.23 $284.95
Resistance Level $75.13 $298.69
Average True Range (ATR) 3.62 8.02
MACD 2.05 0.11
Stochastic Oscillator 95.30 91.50

Price Performance

Historical Comparison
ENTG
PEN

About ENTG Entegris Inc.

Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: